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of the CD28 response (Green et al., 1994; Walunas et
al., 1994). Activation of the CD28 surface receptor has
been shown to be essential for primary T cell responses
Summary in vivo (Schwartz, 1992). T cell–dependent antibody re-
sponses and graft rejection in mice can be suppressed
CD28 response elements (CD28REs) within cytokine by administration of a soluble form of the CTLA-4 recep-
promoters are variant NF-kB-binding sites and are es- tor (Linsley et al., 1992; Lenschow et al., 1992).
sential for transcription in response to CD28 receptor A CD28 response element (CD28RE) was first identi-
activation in T cells. We show that the CK-1 element fied in the IL-2 promoter, and this element showed se-
(CD28RE) within the GM-CSF promoter binds the RelA quence similarity to the previously identified CK-1 ele-
and c-Rel transcription factors in response to CD28 ments in the GM-CSF and IL-3 promoters (Fraser et al.,
activation. We further show that the high mobility 1991). The IL-2 CD28RE is not required for PMA/Ca21
group protein HMG I(Y) can bind to the CD28REs of ionophore activation, but is essential for CD28 costimu-
both GM-CSF and IL-2 and that this binding is critical lation (Fraser et al., 1991). It was subsequently shown
for c-Rel, but not RelA, binding. A second NF-kB site that the GM-CSF and IL-3 CK-1 elements were also
in the GM-CSF promoter that binds p50 and RelA, but required for CD28 activation of these genes (Fraser and
neither c-Rel nor HMG I(Y), failed to respond to CD28 Weiss, 1992). The CK-1/CD28REs are not responsive to
activation. Expression of HMG I or c-Rel antisense PMA/Ca21 ionophore but, interestingly, these elements
RNA inhibited CD28 activation of the IL-2 and GM-CSF are also required for transactivation by the type 1 human
T leukemia virus Tax protein (Himes et al., 1993, 1996;promoters, implying that HMG I(Y) enhancement of
Li and Siekevitz, 1993).c-Rel binding plays an important role in the activity of
A number of experiments including gene knockout ofthe CD28REs.
the relA (encoding the p65 [RelA] component of NF-kB)
and c-rel genes have shown that NF-kB/Rel transcrip-
Introduction tion factors are essential for transcriptional activation
of cytokine genes (Beg et al., 1995; Kontgen et al., 1995;
Activation of T cells through their antigen-specific T Lederer et al., 1994). Investigation of the mechanism of
cell receptor results in the coordinate expression of a CD28 receptor–mediated costimulation has also dem-
number of cytokine genes, such as interleukin 2 (IL-2), onstrated the importance of NF-kB/Rel proteins. The
IL-3, granulocyte/macrophage colony-stimulating fac- IL-2 CD28RE has been shown to bind NF-kB and c-Rel
tor (GM-CSF), and interferon-g. Signal transduction transcription factors in response to PMA/Ca21 iono-
through the T cell receptor leads to activation of two phore, and costimulation through the CD28 receptor
distinct signal transduction pathways (reviewed by results in a strong enhancement of transcription factor
Weiss et al., 1987; Weiss and Littman, 1994). Phosphati- binding (Verweij et al., 1991; Ghosh et al., 1992; Lai et
dylinositol (4,5)bisphosphate hydrolysis results in acti- al., 1995).
vation of both protein kinase C and the calmodulin- We have previously shown that a region of the GM-
dependent phosphatase, calcineurin (Weiss et al.,1987). CSF promoter, containing the CK-1 element as well as
Treatment of T cells with phorbol myristate acetate an adjacent classical NF-kB site, can confer CD28 re-
(PMA) and calcium ionophore can mimic T cell receptor sponsiveness on a heterologous promoter (Himes et al.,
binding by direct activation of these two pathways. The 1996). In this study, we determined that although the
transcription factor complexes NF-AT, AP-1, and NF- GM-CSF kB element was required for activation by
kB are all activated by T cell receptor activation or PMA/ PMA/Ca21 ionophore, it does not respond to costimula-
Ca21 ionophore stimulation (reviewed by Serfling et al., tion through the CD28 receptor. Conversely, the GM-
1995). CSF CK-1 was required for costimulation by CD28, but
Activation of T cells through the T cell receptor alone, not for activation by PMA/Ca21 ionophore alone
however, is not sufficient for high level production of We analyzed the basis of the specificity of the CK-1
cytokines (Weiss et al., 1987). Secondary signals from and kB elements by identifying the proteins that interact
the antigen-presenting cell (APC), referred to as costi- with the GM-CSF and IL-2 CD28REs and the GM-CSF
kB element. We show here that binding of the smallmulation, are required for complete T cell activation.
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nuclear protein high mobility group I(Y) (HMG I(Y)), and
its ability to potentiate the binding of c-Rel but not RelA
to the GM-CSF CK-1 and the IL-2 CD28RE, may deter-
mine the response of these elements to CD28. These
data help to explain the specificity of CD28REs and
provide a basis for understanding deficient production
of IL-2 and GM-CSF by T cells from c-rel 2/2 mice
(Kontgen et al., 1995; Gerondakis et al., 1996).
Results
Differential Response of the GM-CSF CK-1
and kB Binding Sites to PMA/Ca21
Ionophore or CD28
We have previously shown that the region of the GM-
CSF promoter containing the CK-1 and kB elements can
confer CD28 responsiveness on a heterologous pro-
moter (Himes et al., 1996). To determine the relative
role of each element in response to either PMA/Ca21
ionophore or CD28 activation, we used reporter con-
structs containing a specific mutation in either the CK-1
element (pCK-1Mluc) or the kB element (pkBMluc) within
the 654 bp (2626 to 128) proximal promoter of GM-
CSF (Figure 1A). Jurkat T cells transiently transfected
with wild-type (pGMluc) or mutant reporter constructs
were treated with either PMA/Ca21 ionophore or PMA/
Ca21 ionophore and activating antibody to CD28
(a-CD28). Mutation of the CK-1 element had little effect
on transcriptional activation of the GM-CSF promoter
in response to PMA/Ca21 ionophore, but resulted in total
loss of costimulation by a-CD28 when compared with
activation of the wild-type GM-CSF promoter (Figure
1B). Mutation of the kB element, on the other hand,
resulted in an 80% loss of the wild-type response to
Figure 1. Transcriptional Activation of Reporter Vectors Containing
PMA/Ca21 ionophore stimulation (Figure 1B). This low Regulatory Regions from the GM-CSF Gene
level activation by PMA/Ca21 ionophore was, however,
(A) Reporter constructs used to assess the activation of the GM-
still augmented by CD28 activation (1.9-fold compared CSF promoter by CD28 activation. pGMluc contains the wild-type
with 2.6-fold for pGMluc; Figure 1B), but the overall level GM-CSF promoter, while pCK-1Mluc and pkBMluc contain muta-
tions in the CK-1 and kB sites, respectively. pGM-CK-1(2),of the response was greatly reduced.
pGMCD28RE(3), and pGMkB(3) each contain multiple copies of theReporter constructs were then made containing multi-
CK-1 region, the CD28RE or CK-1 element, and the kB element,ple copies of the GM-CSF CK-1 element (pGMCD28RE(3)),
respectively, in the pTK81 vector.
the GM-CSF kB element (pGMkB(3)), or the entire CD28- (B) We transfected 5 mg of each luciferase reporter construct into
responsive region containing both elements (pGMCK- Jurkat T cells. Specific cells were then stimulated with PMA/Ca21
1(2)) cloned upstream of a minimal 81 bp herpes simplex ionophore (PMA/Ion) or PMA/Ca21 ionophore and activating anti-
body to CD28 (plus a-CD28) or were not stimulated. We used 10virus (HSV) thymidine kinase promoter (Figure 1A). Jur-
mg of cell lysate in luciferase assays. Luciferase activity was mea-kat T cells were transfected with these constructs and
sured by a scintillation counter; values are in CPM 3 106, columnsstimulated as above. Results showed that the construct
in graph represent the mean, and error bars represent the SEM ofcontaining the whole CD28-responsive region had a low
three replicate transfections.
level response to PMA/Ca21 ionophore (4-fold), and fur-
ther treatment with a-CD28 antibody resulted in a 4-fold
Ca21 ionophore, but it is not essential for (although itincrease in reporter activity over PMA/Ca21 ionophore
may contribute to) the CD28 response, since the fullalone (Figure 1B). The GM-CSF CK-1 element alone,
level of activation cannot be attained when this elementhowever, was unable to respond significantly to PMA/
is mutated. This pattern of activation suggests that theCa21 ionophore alone or with CD28 stimulation (Figure
kB element is required for promoter activation, whereas1B). The GM-CSF kB element alone showed a response
the CK-1 element acts as a specific enhancer for costi-to PMA/Ca21 ionophore (4.5-fold) that was not increased
mulatory signals.significantly by costimulation with a-CD28 (Figure 1B).
These results showed that the GM-CSF CK-1 element
The GM-CSF CD28RE and kB Elements Bindis specifically required for response to CD28 activation.
Different Complexes of NF-kB/RelThe CK-1 element, however, cannot function alone and
Transcription Factorsrequires either the kB in the case of the multimerized
To understand why the CK-1 and kB elements of GM-constructs or other promoter elements where the kB
CSF respond distinctly to either PMA/Ca21 ionophore orsite is mutated to generate a CD28 response. The down-
stream kB element is essential for stimulation with PMA/ CD28, we performed an analysis of transcription factor
HMG I(Y) and Rel Binding to the GM-CSF and IL-2 Genes
481
Figure 2. Identification of Transcription Factors That Bind to the GM-CSF CK-1 and kB Elements
Gel shift analysis was performed using approximately 3 mg of nuclear extract from nonstimulated Jurkat T cells (minus) and cells stimulated
with PMA/Ca21 ionophore (P/I) or PMA/Ca21 ionophore and activating antibody to CD28 (plus a-CD28) for 1 and 6 hr. Identification of specific
NF-kB/Rel transcription factors was performed by preincubating extracts with polyclonal antibody to either p50, RelA, or c-Rel. Mobility shift
assays were performed using 32P-labeled oligonucleotide probes containing either the GM-CSF CK-1 (top) or the GM-CSF kB element (bottom).
Only the region of the gel showing the inducible complexes, designated (a) for CK-1 and (b) for kB, and the supershifted complexes are
shown.
binding. Electrophoretic mobility shift assays were per- the CK-1 probe, with the RelA antibody showing the
greatest reduction of the inducible protein complex. Atformed using nuclear extracts from cells treated with
PMA/Ca21 ionophore or both PMA/Ca21 ionophore and 6 hr poststimulation, both RelA and c-Rel antibodies
again showed supershifted bands; however, the c-Rela-CD28. Nuclear extracts were made after 1 and 6 hr
treatment with each stimulus, since previous work antibody produced a greater reduction of inducible pro-
tein binding and a stronger supershift when CD28 wasshowed two peaks of protein binding at thesetimepoints
poststimulation with PMA/Ca21 ionophore to the oligo- activated (Figure 2, top, complex a). Treatment with p50
antibody resulted in no supershifted bands and hadnucleotide probe containing the GM-CSF CK-1 element
(Himes et al., 1996). A significant increase in inducible no effect on protein binding to the CK-1 element (Figure
2, top).protein binding to the GM-CSF CK-1 probe was ob-
served at both 1 and 6 hr with PMA/Ca21 ionophore and A different pattern of binding was seen in the GM-
CSF kB oligonucleotideprobe. At both1 and 6 hr poststi-a-CD28 treatment combined compared with PMA/Ca21
ionophore alone (Figure 2, top, complex a). The oligonu- mulation with PMA/Ca21 ionophore and a-CD28, su-
pershifts were seen with the RelA antibody, and both thecleotide probe containing the GM-CSF kB element also
showed an increase in protein binding at 1 hr poststimu- p50- and RelA-specific antibodies resulted in complete
loss of protein complex b (Figure 2, bottom). The c-Rellation with PMA/Ca21 ionophore and a-CD28 compared
with PMA/Ca21 ionophore alone, but no significant in- antibody had no effect on protein binding to the kB
element at either timepoint. The same pattern was ob-crease was seen at 6 hr (Figure 2, bottom, complex b).
The inducible protein complexes forming on the CK-1 served with extracts from PMA/Ca21 ionophore–stim-
ulated cells (data not shown).and kB elements, which we have previously identified
as NF-kB-like proteins (Himes et al.,1996), have different These data showed that CD28 can mediate significant
increases in NF-kB/Rel binding to the GM-CSF CK-1mobilities despite the similar length of each probe. Spe-
cific antibodies to NF-kB/Rel transcription factors were element, but not to the kB element. Antibody analysis
showed that the GM-CSF CK-1 can strongly bind bothused to identify the proteins in each complex. Nuclear
extracts from cells treated with PMA/Ca21 ionophore or RelA and c-Rel, but not as a heterodimer with p50. There
was no apparent qualitative difference in the proteinsPMA/Ca21 ionophore and a-CD28 for either 1 hr or 6 hr
were treated with antibody to either p50, RelA, or c-Rel binding to CK-1 in extracts from cells treated with PMA/
Ca21 ionophore or PMA/Ca21 ionophore plus a-CD28,prior to binding to the GM-CSF CK-1 probe. At 1 hr after
stimulation with either PMA/Ca21 ionophore or PMA/ but a significant increase in c-Rel binding was observed
at later timepoints following CD28 activation. Con-Ca21 ionophore plus a-CD28, both RelA and c-Rel anti-
body treatments resulted in supershifted complexes on versely, the GM-CSF kB element does not bind c-Rel
Immunity
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groove within the interferon-b kB element has been
shown to enhance NF-kB binding (Thanos and Maniatis,
1992). To determine whether HMG I(Y) proteins can bind
to the GM-CSF CK-1 and IL-2 CD28RE, we performed
gel shift analyses using the GM-CSF CK-1 and IL-2
CD28RE probes and recombinant HMG I(Y). The GM-
CSF kB element probe was also tested, and the consen-
sus NF-kB-binding site from the human immunodefi-
ciency virus (HIV) long terminal repeat (LTR) was used
as a control. Results showed that HMG I(Y) proteins can
bind to both the GM-CSF CK-1 element and the IL-2
CD28RE, although protein binding was considerably
weaker to the GM-CSF CK-1 element compared with
the IL-2-binding site (Figure 3B). This lower affinity is
likely to result from the shorter, three base AT sequence
in the GM-CSF CD28RE compared with the five base
AT sequence in the IL-2-binding site (Figure 3A). The
GM-CSF kB and HIV 39 kB elements both showed no
HMG I(Y) binding (Figure 3B).
The addition of affinity-purified polyclonal antibody to
HMG I(Y) (a–HMG I(Y)) was able to prevent binding of
recombinant HMG I(Y) protein to the GM-CSF CK-1 and
interferon-b probes, confirming the specificity of HMG
I(Y) binding (Figure 3C). The addition of affinity-purified
preimmune serum used as a control had no effect on
HMG I(Y) binding.
HMG I(Y) Specifically Influences c-Rel
but Not RelA Binding to CD28REs
The binding of HMG I(Y) proteins to the interferon-b kB
element was previously shown to be essential for high
affinity binding of NF-kB proteins (Thanos and Maniatis,
Figure 3. Analysis of HMG I(Y) Binding to the GM-CSF CK-1 and 1992). We thus wished to determine whether the binding
IL-2 CD28RE of HMG I(Y) to the GM-CSF CK-1 and IL-2 CD28RE could
(A) Sequence alignment of the CD28-responsive elements GM-CSF modify the inducible binding of NF-kB/Rel proteins. The
CK-1 and IL-2 CD28RE and the kB elements from interferon-b, GM-
GM-CSF kB element, which does not bind HMG I(Y),CSF, and HIV LTR. AT sequences that represent possible HMG
was used as a control. Experiments were performedI(Y)–binding sites are stippled.
using nuclear extracts from cells stimulated with PMA/(B) Binding of HMG I(Y) to 32P-labeled oligonucleotide probes con-
taining the GM-CSF CK-1, IL-2 CD28RE, GM-CSF kB, and HIV LTR Ca21 ionophore and a-CD28 for 1 or 6 hr treated with
kB elements. A titration of 1, 5, and 10 ng of recombinant HMG I(Y) either preimmune antibody or a–HMG I(Y) shown to pre-
protein was used in the binding assays. vent HMG I(Y) binding (data discussed above; Figure
(C) Radiolabeled oligonucleotide probes containing the GM-CSF
3C). Addition of a–HMG I(Y) mediated a significant de-CK-1 or interferon-b kB element were incubated with 10 ng of re-
crease in binding at 6 hr poststimulation to the induciblecombinant HMG I(Y) alone (minus), with affinity-purified antibody to
protein complex on both the GM-CSF CK-1 and IL-2HMG I(Y) (a–HMG I(Y); plus), or with affinity-purified preimmune
antibody (prI). Complexes were analyzed on 12% polyacrylamide CD28RE probes (Figure 4A). a–HMG I(Y) had a smaller
gels containing 0.53 TBE. effect on protein binding at 1 hr poststimulation. The
addition of a–HMG I(Y) had no effect on NF-kB binding
to the GM-CSF kB element (Figure 4A).
and binds RelA primarily as a heterodimer with p50 in The results described above suggested the possibility
the presence or absence of CD28 activation. that HMG I(Y) was affecting the binding of only spe-
cific complexes formed on the GM-CSF CK-1 or IL-2
CD28RE, since the effect was mainly observed on theHMG I(Y) Proteins Bind to the GM-CSF
and IL-2 CD28REs major complex at the 6 hr timepoint (Figure 4A). We
used supershifting antibody to RelA and c-Rel to betterBoth the GM-CSF CK-1 element and the IL-2 CD28RE
show only partial sequence homology to the immuno- identify specific losses of inducible protein binding with
a–HMG I(Y)-mediated inhibition of HMG I(Y) binding.globulin k (Igk) NF-kB site (7 of 10 and 6 of 10, respec-
tively; Figure 3A). Part of this divergence is the presence Nuclear extracts from cells stimulated for 1 and 6 hr
with PMA/Ca21 ionophore and a-CD28 were combinedof an AT sequence in the center of the GM-CSF CK-1
and IL-2 CD28RE (Figure 3A). The AT sequence within to ensure high levels of both RelA and c-Rel in the com-
plexes. These extracts were treated with preimmunethe IL-2 CD28RE is a perfect match to the HMG I(Y)–
binding site within the NF-kB-binding site in the inter- serum or a–HMG I(Y) and then further treatedwith super-
shifting antibody to either RelA or c-Rel. Inclusion offeron-b gene (Figure 3A). HMG I(Y) binding to the minor
HMG I(Y) and Rel Binding to the GM-CSF and IL-2 Genes
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Figure 4. Effect of Antibody Inhibition of HMG I(Y) Binding on NF-kB/Rel Binding to the GM-CSF CK-1, kB, and IL-2 CD28RE Elements
(A) Gel shift analysis was performed using oligonucleotide probes containing the GM-CSF CK-1 element, IL-2 CD28RE, or GM-CSF kB element
and approximately 3 mg of nuclear extract from nonstimulated Jurkat T cells (ns) or cells stimulated with PMA/Ca21 ionophore and a-CD28
for 1 and 6 hr. Extracts were treated with either preimmune antibody (minus) or a–HMG I(Y) (plus) prior to the binding reactions.
(B) Gel shift analysis with a mixture of nuclear extracts from cells stimulated with PMA/Ca21 ionophore and a-CD28 for 1 and 6 hr (P/I plus
a-CD28) and the GM-CSF CK-1 and IL-2 CD28RE probes. Extracts were treated with a–HMG I(Y) as above, except extracts were also incubated
with supershifting antibody to either RelA or c-Rel. The figure shows the region of the gel containing the inducible DNA–protein complexes
and supershifted bands for each stimulus.
a–HMG I(Y) resulted in a complete loss of the ability to Hence, HMG I(Y) binding to the GM-CSF CK-1 and
IL-2 CD28RE appears to be required for high level c-Relsupershift c-Rel binding on the GM-CSF CK-1 and IL-2
CD28RE probes. Both elements retained the ability to binding, but not RelA binding. In contrast with both con-
sensus NF-kB-binding sites and the CD28REs of GM-supershift RelA, but with a slight reduction in the inten-
sity of the supershifted band (Figure 4B). CSF and IL-2, the GM-CSF kB element acts specifically
as an extremely low affinity c-Rel-binding site, sinceAnalysis of recombinant protein binding was used to
verify the specific role of HMG I(Y) protein on c-Rel, but no binding can be observed with nuclear extracts or
recombinant c-Rel protein. In contrast with the resultsnot RelA, binding to the GM-CSF and IL-2 CD28REs.
The oligonucleotide probes containing either the GM- for c-Rel, the binding of RelA either to the GM-CSF CK-1
and IL-2 CD28RE or to any of the control probes wasCSF CK-1 or IL-2 CD28RE were analyzed for recombi-
nant c-Rel or RelA binding on their own or in association not affected by the presence of HMG I(Y) (Figure 5).
with recombinant HMG I(Y). The GM-CSF kB element
probe, which showed no c-Rel binding with nuclear ex-
tracts, was also analyzed for recombinant protein bind- Expression of HMG I and c-Rel Antisense
RNAs Inhibits Activation of the IL-2ing. The IgkB and HIV 39 kB probes were used as con-
trols because these elements bind c-Rel and RelA but and GM-CSF Promoters
The requirement of HMG I(Y) proteins for c-Rel bindingdo not bind HMG I(Y) (Du et al., 1993; Figure 3B).
The results showed that c-Rel binding to both the to the CD28REs indicated that loss of HMG I(Y) or
c-Rel protein expression would affect transcriptional ac-GM-CSF and IL-2 CD28REs was enhanced by the pres-
ence of recombinant HMG I(Y) (Figure 5). The GM-CSF tivation of IL-2 or GM-CSF in response to CD28 activa-
tion. To investigate this possibility, we used a plasmidkB element failed to bind c-Rel (Figure 5), consistent
with the absence of observable c-Rel binding in nuclear containing full-length cDNA for the HMG I protein in-
serted in the antisense orientation downstream fromextracts. c-Rel binding to the IgkB or HIV 39 kB probes
was not enhanced with addition of HMG I(Y); instead, a the immediate-early promoter of cytomegalovirus (CMV)
(RcCMVIGMH) to overexpress antisense RNA and inhibitslight decrease in binding to the HIV 39 kB was observed
(Figure 5). HMG I protein synthesis. A plasmid containing the
Immunity
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Figure 5. HMG I(Y) Enhancement of Recombinant c-Rel Binding to
the GM-CSF CK-1 and IL-2 CD28RE
Gel shift analysis was performed using oligonucleotide probes con-
taining the GM-CSF CK-1 element, IL-2 CD28RE, GM-CSF kB ele-
ment, Igk enhancer kB element (IgkB), and HIV LTR 39 kB element.
Oligonucleotides were incubated with dilute recombinant c-Rel or
RelA protein from Escherichia coli lysates either with (plus) or with-
out (minus) 10 ng of recombinant HMG I(Y). The figure shows the
region of the gel containing the recombinant protein–DNA complex.
unique region of the c-Rel coding sequence, in the ab-
sence of the rel homology domain, inserted in the anti-
sense orientation with respect to the CMV promoter,
was also used to inhibit c-Rel protein synthesis. These
antisense plasmids were cotransfected at increasing
amounts together with the GM-CSF and IL-2 reporter
constructs into Jurkat cells and treated with PMA/Ca21
ionophore with or without a-CD28. With antisense c-Rel,
a dose-dependent inhibition of both promoters was ob-
served, with maximum reductions of 50% for IL-2 and
40% for the GM-CSFpromoter seen in response to PMA/
Ca21 ionophore and a-CD28 (Figure 6A). Smaller maxi-
mum reductions of 32% and 20% for IL-2 and GM-CSF,
respectively, were observed in the response to PMA/
Ca21 ionophore alone at the maximum level of c-Rel
antisense plasmid (Figure 6A).The function of pGMkB(3),
which contains multiple copies of the GM-CSF kB ele-
ment that does not bind c-Rel (Figure 2, bottom, and
Figure 5), was not affected by antisense c-Rel (Fig-
ure 6A).
Expression of antisense HMG I resulted in a dose-
dependent reduction of both GM-CSFand IL-2 promoter Figure 6. HMG I(Y) and c-Rel Are Both Required for CD28 Activation
of the GM-CSF and IL-2 Promotersactivity, with a maximum reduction of 92% seen with the
IL-2 promoter and 45% seen with the GM-CSF promoter (A) Inhibition of GM-CSF and IL-2 promoter function by expression
of antisense RNA for c-Rel. We cotransfected 5 mg of reporter con-following CD28 activation (Figure 6B). A similar reduc-
structs containing the GM-CSF (pGMluc) or IL-2 (pIL-2luc) promot-tion (86% for IL-2 and 44% for GM-CSF) was seen when
ers into Jurkat T cells with increasing amounts of a RcCMV plasmidthe cells were treated with PMA/Ca21 ionophore alone
expressing antisense c-Rel RNA (RcCMVCTRel). The base RcCMV
(Figure 6B). Expression plasmids were also cotrans- vector was used to ensure equal amounts of DNA (30 mg) in each
fected with a reporter vector containing five copies of transfection. The pGMkB plasmid was used as a control for nonspe-
the Igk gene enhancer NF-kB-binding site (IgkB) cloned cific effects of c-Rel antisense expression. Cells were stimulated
with PMA/Ca21 ionophore with or without a-CD28 for 8 hr prior toupstream of the HSV thymidine kinase promoter (pIg-
harvesting. Luciferase activity was measured using the Packard TopKLuc). This vector was used as a negative control, since
HMG I(Y) and Rel Binding to the GM-CSF and IL-2 Genes
485
the Igk element responds to PMA/Ca21 ionophore but at the level of subunit dimerization and selective binding.
The analysis of transcription factor binding to each ele-does not bind HMG I(Y). Antisense HMG I expression
had no effect on luciferase activity generated from this ment showed that the CD28RE CK-1 was able to bind
high levels of c-Rel and RelA in a CD28-dependent man-plasmid (Figure 6A).
These results imply that both HMG I(Y) and c-Rel are ner. Conversely, the kB element does not appear to bind
c-Rel and can only bind RelA as a complex with the p50important for the function of the GM-CSF and IL-2 pro-
moters, with c-Rel playing a more critical role in CD28 protein.
The ability of c-Rel to bind to the CK-1 but not the kBresponses.
element may be critical for generating a CD28-specific
response. Previous research has shown that CD28 acti-Antisense HMG I Specifically Inhibits
vation can result in accelerated nuclear translocation ofthe Activity of the IL-2 CD28RE
c-Rel (Bryan et al., 1994), and our results and otherSince HMG I(Y) is a promiscuous binding protein and is
reports show a significant increase in c-Rel binding tolikely to bind to any AT-rich sites in the gene promoters,
CD28REs (Figure 2; Verweij et al., 1991; Ghosh et al.,we wished to determine whether antisense HMG I spe-
1992). The c-Rel transcription factor has also beencifically affected the function of the CD28 response re-
shown to be phosphorylated in response to activationgions alone. The CAT reporter vector, pMAP1, which
of the CD28 receptor (Bryan et al., 1994), and, althoughcontains six copies of the IL-2 CD28-responsive region
this phosphorylation has not yet been correlated withcloned upstream of the HSV thymidine kinase promoter,
biological activity, previous work on the Jun transcrip-was used. Expression of antisense HMG I RNA resulted
tion factor has shown that phosphorylation in responsein inhibition of the IL-2 CD28-responsive region in re-
to CD28 signaling is associated with transactivationsponse to PMA/Ca21 ionophore and a-CD28 stimulation.
competence (Rincon and Flavell, 1994).A dose-dependent inhibition of pMAP1 was seen, with
The antisense experiments presented here show that50% inhibition of reporter activity observed at the maxi-
c-Rel is important for the activation of the GM-CSF andmum amount of RcCMVIGMH transfected (Figure 6C).
IL-2 promoters. The role of c-Rel was also clearly shownAntisense expression had no effect on the control re-
in the deficient production of both GM-CSF and IL-2 inporter plasmid, pIgKCAT, at the maximum level of plas-
c-rel 2/2 mice. T cells from mice lacking the c-rel genemid transfected (Figure 6C). These results show that
showed a 13-fold decrease in GM-CSF production andthe binding of HMG I(Y) to the CD28RE has functional
a 50-fold decrease in IL-2 production compared withsignificance.
wild-type cells when stimulated with activating antibody
to the T cell receptor and the CD28 receptor (KontgenDiscussion
et al., 1995; Gerondakis et al., 1996). While antisense
c-Rel appeared to have a greater inhibitory effect inThe results described here show that the GM-CSF kB
CD28-activated cells, inhibition was also observed whenand CK-1 elements play major roles in PMA/Ca21 iono-
cells were treated with only PMA/Ca21 ionophore. Bothphore and CD28 responses, respectively, despite bind-
these results and results from the c-Rel-deficient miceing related NF-kB/Rel family transcription factors. This
show a role for c-Rel in response to PMA/Ca21 iono-specific response appears to be related to the formation
phore. This was unexpected, since c-Rel appears toof distinct complexes of NF-kB/Rel transcription factors
bind only to the CK-1 element, which is not requiredon these elements, suggesting that regulation can occur
for the response to PMA/Ca21 ionophore (Figure 1). In
addition, the antisense c-Rel had no effect on the func-
tion of the other known NF-kB site, the kB element, in
the GM-CSF promoter. It is possible that there are otherCount luminescence counter, and the numbers are given as counts
per second (CPS) 3 103. Columns represent the mean, and error unidentified c-Rel-binding sites within the GM-CSF and
bars the SEM, of five replicate assays. IL-2 promoters, or, more likely given the complex inter-
(B) Inhibition of GM-CSF and IL-2 promoter activity by expression play of the transcription factors affecting GM-CSF and
of antisense RNA for HMG I. The experiments were carried out as IL-2 transcription, that the reduction in c-Rel levels may
described in (A), except the RcCMV-based plasmid RcCMVIGMH
be affecting the function or expression of these factors.was used for antisense HMG I expresssion. A construct containing
The results reported here, however, show a strongfive copies of the Igk kB site that does not bind HMG I(Y) in the
correlation between high affinity binding of c-Rel andpTK81luc reporter plasmid (pIgKluc) was used as a negative control.
(C) Inhibition of the CD28 response of the IL-2 CD28RE with anti- transcriptional activation of the human GM-CSF and
sense HMG I. We cotransfected 5 mg of the plasmid pMAP1, con- IL-2 promoters in response to CD28. In the GM-CSF
taining six copies of the IL-2 CD28-responsive region cloned up- promoter, the CK-1 element binds c-Rel, whereas the
stream of the HSV thymidine kinase promoter in a CAT reporter
kB element does not and, moreover, does not respondvector, into Jurkat T cells with a titration (10, 20, and 30 mg) of
to CD28 activation. In addition, the function of the kBthe plasmid expressing antisense HMG I RNA (pRcCMVIGMH) and
element was not affected by antisense c-Rel expression.nonexpressing plasmid RcCMV to equalize DNA levels. Cells were
then stimulated with PMA/Ca21 ionophore plus a-CD28. A CAT re- The IL-2 CD28RE also acts as a high affinity binding site
porter construct containing five copies of the Igk NF-kB-binding for c-Rel, and IL-2 production can be correlated with
site cloned upstream of the HSV thymidine kinase reporter was c-Rel nuclear expression in human peripheral blood T
transfected as described above, except either 30 mg of RcCMV or
cells (Figure 4B; Bryan et al., 1994). The specific require-30 mg of RcCMVIGMH was used. CAT assays employed 2 mg of cell
ment for c-Rel binding in the response to CD28 mayextract and were quantified using a phosphorimager. The columns
explain the lack of function of these sites, in particularrepresent the mean, and error bars the SEM, of three replicate
transfections. the GM-CSF CK-1, in response to such NF-kB-activating
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agents as tumor necrosis factor a, IL-1b, and PMA the full-length GM-CSF and IL-2 promoters imply that
it may also have a more general role. There are many(Shannon et al., 1990; Kuczek et al., 1991). These agents
other AT-rich sequences in both the IL-2 and GM-CSFfail to activate high levels of c-Rel binding to the GM-
promoters that are possible binding sites for HMG I(Y).CSF CK-1 element (unpublished data).
Characterization of additional HMG I(Y)–binding sitesc-Rel appears to bind to the CD28REs of GM-CSF
will be required to determine whether HMG I(Y) can pro-and IL-2 in a manner different from its binding to the
mote similar transcription factor interactions on the IL-2consensus NF-kB-binding sites in the HIV LTR or Igk
and GM-CSF promoters and assemble functional pro-enhancer. Unlike these sites, high affinity binding of
moter complexes.c-Rel to the GM-CSF CK-1 and IL-2 CD28RE requires
The GM-CSF and IL-2 CK-1 (CD28RE) sites have alsoHMG I(Y) proteins. The ability of antisense HMG I RNA
been shown to bind NF-AT proteins (McCaffrey et al.,to inhibit the function of the IL-2 CD28RE confirmed that
1992; Rooney et al., 1995; unpublished data). While NF-the HMG I(Y) proteins play a specific regulatory role in
AT-like proteins were identified binding to the IL-2the activity of these elements. HMG I(Y) proteins and
CD28RE, no increase in binding was seen followingc-Rel areboth expressed by T cells in response to stimu-
CD28 activation (Rooney et al., 1995). Functional studieslation with PMA/Ca21 ionophore (Bryan et al., 1994;
using a composite NF-AT/AP1 site from the IL-4 pro-Friedmann et al., 1993); hence, these proteins should
moter have shown that this site is CD28 responsivebe capable of simultaneous binding to CD28REs within
(Rooney et al., 1995). However, the AP-1 half, and notthe nucleus. HMG I(Y) binding to AT-rich sequences
the NF-AT-binding half, was implicated in the CD28 acti-within or adjacent to many transcription factor–binding
vation. The IL-2 CD28RE also has an adjacent AP-1 sitesites has been shown to augment binding to these sites
that is required for the function of the CD28RE (Li and(Thanos and Maniatis, 1992; Du and Maniatis, 1994;
Siekevitz, 1993). It has also recently been shown thatLewis et al., 1994; Chuvpilo et al., 1993; John et al.,
NF-AT can be activated in a cyclosporin-independent1995). The ability of HMG I(Y) to affect NF-kB binding
manner by PMA and CD28 activation and thereforehas been described for the interferon-b and E-selectin
could possibly mediate the cyclosporin A–resistantpromoters (Thanos and Maniatis, 1992; Lewis et al.,
CD28 activation (Ghosh et al., 1996). It is possible that1994). Here, however, we show that HMG I(Y) has a
different T cell lines or clones show preference for NF-ATspecific effect on the binding of only one member of
or NF-kB/Rel in the CD28 response. The use of primary T
the NF-kB/Rel family of proteins to both the GM-CSF
cells from both normal mice and those deficient in the
CK-1 and IL-2 CD28RE. This effect of HMG I(Y) on c-Rel
specific transcription factors may help to resolve this
but not RelA binding may result from specific modifica-
issue. As suggested by Rooney et al. (1995), given the
tion of either c-Rel or HMG I(Y) allowing productive inter-
different kinetics of NF-AT and c-Rel activation, it is
action to occur either in solution or on the DNA. While
likely that they both play important roles, but do so at
c-Rel is phosphorylated following CD28 activation different timepoints following T cell activation.
(Bryan et al., 1994), it is not known whether HMG I(Y) The requirement for HMG I(Y)–dependent regulation
levels or modification are affected by CD28. The selec- of IL-2 may be linked to the close correlation between
tivity of HMG I(Y) for a particular transcription factor HMG I(Y) protein expression and cell proliferation (John-
family member has been previously reported for the Oct son et al., 1990). This association is supported by
proteins binding to the HLA-DRA gene (Abdulkadir et evidence that HMG I(Y) proteins are also important
al., 1995). In that system, the binding of Oct-2A, but not for transcriptional activation of the IL-2Ra promoter
Oct-1 or Oct-2B, was facilitated by the presence of HMG through the interaction of HMG I(Y), NF-kB, and Elf-1
I(Y). These findings suggest that HMG I(Y) may play an (John et al., 1995), indicating that HMG I(Y) is necessary
important role in the generation of specific responses for maintenance of the IL-2/IL-2Ra autocrine loop. The
by acting as a selectivity factor for specific members of importance of linking growth factor expression to HMG
transcription factor families and assembling these on I(Y) may then be connected to the broad role HMG I(Y)
the DNA. can play ingene activation and hence cell growth. Future
HMG I(Y) proteins can affect gene regulation in other investigation of c-Rel and HMG I(Y) expression and their
ways in addition to enhanced transcription factor bind- importance during IL-2-dependent clonal expansion of
ing. The presence of HMG I(Y) proteins can allow asso- cells will be needed to support this hypothesis.
ciation between different complexes of transcription Both the GM-CSF and IL-2 promoters contain classi-
factors, and there is evidence that it can promote inter- cal NF-kB (p50/RelA)-binding sites, which are important
action between ATF-2 and NF-kB in the interferon-b in activation by mitogen (Hughes and Pober, 1996). Our
gene (Thanos and Maniatis, 1995; Du et al., 1993). It has results show that the distinct response of the GM-CSF
also recently been shown that HMG I(Y) contributes to and IL-2 CK-1/CD28RE elements to CD28 stimulation,
the reversal of intrinsic DNA bends in the interferon-b and not mitogen, may be related to specific augmen-
promoter, allowing predicted protein–protein interac- tation of c-Rel binding by HMG I(Y). This specificity indi-
tions to occur (Falvo et al., 1995). It has been proposed cates that, in addition to the general architectural role
that HMG I(Y) involvement may be a general feature of HMG I(Y) plays in transcription factor binding and asso-
the architecture of inducible gene promoters or en- ciation, HMG I(Y) can also play a role in selection of
hancers (Thanos and Maniatis, 1995). This proposal is specific members of transcription factor families. Future
further borne out by our results showing its involvement analysis of protein modifications and the specific archi-
in GM-CSF and IL-2 activation. While we have shown tectural constraints of HMG I(Y)/c-Rel binding will be
that HMG I(Y) can bind to, and is functionally important needed to understand further the functional specificity
of CD28REs.for, the CK-1/CD28REs, the antisense experiments with
HMG I(Y) and Rel Binding to the GM-CSF and IL-2 Genes
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Experimental Procedures Reporter Assays
Cells used for GM-CSF luciferase reporter assays (data in Figure 1)
were lysed 8 hr poststimulation with PMA/Ca21 ionophore andPlasmids and Oligonucleotides
The RcCMV plasmid was supplied by Invitrogen. The RcCMVIMGH a-CD28 by three cycles of freeze–thaw. We used 10 mg of protein
from the cell lysate for luciferase assay according to a previouslyexpression plasmid was made by inserting the full-length HMG I
cDNA in the antisense orientation with respect to the CMV promoter described method (Wood, 1991). Light emission was measured us-
ing a scintillation counter with the coincidence circuit switched off.within the RcCMV plasmid. The RcCMVCTRel expression plasmid
was made using the polymerase chain reaction to generate a cDNA Cells used in CAT assays (data from Figure 6C) were stimulated
with the concentrations of PMA/Ca21 ionophore described abovefragment containing the unique C-terminal end of c-Rel, 11021 to
12036 with respect to the start codon, for insertion into the HindIII and antibody for 6 hr, and then stimulus was removed and cells
were harvested 16 hr later. CAT assays were performed using 2 mgand NotI sites of RcCMV in the antisense orientation with respect
to the CMV promoter. The reporter vectors containingGM-CSF regu- of cell lysate according to a previously published method (Gorman
et al., 1982). A phosphorimager was used to quantitate [14C]chloram-latory regions pGMluc, pCK-1Mluc, pkBMluc, pGMCK-1(2), and
pGMkB(3) have all been described previously (Himes et al., 1993). phenicol and its acetylated derivatives. The antisense luciferase
reporter assays (data from Figures 6A and 6B) were performed usingThe reporter vector pGMCD28RE(3) was made by multimerizing
three copies of the sequence TGATAAGGGCCAGGAGATTCCACAG the Top Count luminometer (Packard). Cells were transfected as
above, and 24 hr posttransfection 1 3 105 cells were plated into topcontaining the GM-CSF CK-1 element and cloning into the BamHI
and HindIII sites in the luciferase reporter vector pTK81 (Nordeen, count plates and stimulated as above. After 8 hr of stimulation,
cells were lysed and analyzed using the Promega luciferase assay1988). The reporter vector pMAP1, containing the IL-2 tax-respon-
sive region, was donated by Dr. Mike Lenardo (National Institutes procedure.
of Health, Bethesda, MD) (Himes et al., 1996). The plasmid pIL-2luc
was made by inserting the ClaI–HindIII fragment from the plasmid Gel Shift Analysis
p15DCX (Mattila et al., 1990), containing the IL-2 promoter from Double-stranded oligonucleotides were end labeled with 32P using
2326 to 145, into the SmaI–HindIII sites of the reporter plasmid T4 polynucleotide kinase. Nuclear extracts from transfected and
pXP1 (Nordeen, 1988). The plasmid pIgKluc was made by inserting stimulated cells were prepared according to the procedure of
a BamHI–HindIII fragment from pIgKCAT, containing five copies of Schreiber et al. (1989). Approximately 3 mg of nuclear extract was
the Igk NF-kB-binding site, into the BamHI–HindIII sites of the re- used for binding assays. The composition of the binding buffer for
porter plasmid pTK81. The oligonucleotides used for gel shift analy- assays using nuclear extracts was 25 mM Tris (pH 7.6), 6 mM MgCl2,
sis contained the following sequences: GM-CSF CK-1, TGATAAGG 0.5 mM DTT, 0.5 mM EDTA, 5% (v/v) Ficoll, 60 mM NaCl, and 1
GCCAGGAGATTCCACAGTTCAGGTAGT; GM-CSF kB, GTTCAGGT mg of poly(dI–dC). All assays contained approximately 0.1 ng of
AGTTCCCCCGCCTCCCT; IL-2 CD28RE, TGGGGGTTTAAAGAAA radiolabeled probe. Electrophoresis was performed on a 5% poly-
TTCCAGAGAGTCATCAG AA; IgkB, AACAGAGGGGACTTTCCG acrylamide gel containing 0.53 TGE buffer (25 mM Tris [pH 8.5],
AGGCCATCT; HIV 39 kB, AGCTTTCCGCTGGGGACTTTCCAGGGA; 0.19 M glycine, 0.2 mM EDTA) for 3 hr at 150 V. The composition
interferon-b kB, AGAAGTGAAAGTGGGAAATTCCTCTGAATAGAGA of the buffer for binding recombinant HMG I(Y) was 40 mM HEPES,
GAGGAC. 70 mM KCl, 1 mM DTT, and 5% (v/v) Ficoll. Conditions for gel shift
analysis using recombinant RelA and c-Rel proteins were as above,
except the binding buffer contained 2 mM MgCl2 (magnesium wasAntibodies and Proteins
required for enhancement of c-Rel binding with HMG I(Y); data not
Rabbit serum containing polyclonal antibodies to RelA and c-Rel
shown). Recombinant RelA and c-Rel protein binding assays were
proteins were donated by Dr. Steve Gerondakis (Walter and Eliza
run on a 5% polyacrylamide gel containing 0.53 TBE buffer (0.5
Hall Institute, Melbourne, Australia) and have been characterized
mM Tris, 42 mM boric acid, 1 mM EDTA [pH 8.3]) for approximately
previously (Grumont and Gerondakis, 1994). Polyclonal antibody to
2 hr at 200 V. Recombinant HMG I(Y) protein binding assays were
p50 was supplied by Santa Cruz Biotechnology. Rabbit polyclonal
run on a 12% acrylamide gel containing 0.53 TBE for approximately
antibodies against human HMG I(Y) proteins have been described
90 min at 200 V.
previously (Disney et al., 1989). Affinity purification of antibodies
followed standard procedures (Harlow and Lane, 1988). Recombi-
Acknowledgmentsnant c-Rel protein (a gift of Dr. Charles Kunsch, Human Genome
Sciences, Bethesda MD) and RelA protein (a gift of Dr. Steve Geron-
Correspondence should be addressed to M. F. S. The work de-dakis) were prepared according to the procedures described in
scribed in this paper was supported by grants from the AustralianKunsch et al. (1992) and Dunn et al. (1994), respectively. The vector
National Health and Medical Research Council and a Common-pET7C carrying the full-length human HMG I(Y) cDNA (Nissen et al.,
wealth AIDS Research Grant. We thank Drs. Steve Gerondakis,1991) was used to express human HMG I protein. Crude recombi-
Charles Kunsch, Mike Lenardo, and Peter Cockerill for their gener-nant protein was extracted and purified by cation-exchange chro-
ous gifts of reagents.matography employing a macro-prep 50S column (Bio-Rad), and
purity was assessed by SDS–polyacrylamide gel electrophoresis.
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